Litcius/Paper detail

Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH)

Shafqat Rasul Chaudhry, Thomas M. Kinfe, Alf Lamprecht, Mika Niemelä, Gergana Dobreva, Daniel Hänggi, Sajjad Muhammad

2020Cytokine28 citationsDOI

Topics & Concepts

MedicineSubarachnoid hemorrhageCerebrospinal fluidCCL5ChemokineModified Rankin ScaleGlasgow Outcome ScaleBiomarkerNeurointensive careInternal medicinePathologyInflammationImmunologyAnesthesiaGlasgow Coma ScaleImmune systemIschemiaIL-2 receptorT cellChemistryBiochemistryIschemic strokeIntracranial Aneurysms: Treatment and ComplicationsNeuroinflammation and Neurodegeneration MechanismsIntracerebral and Subarachnoid Hemorrhage Research
Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH) | Litcius